Add to ORKGUpdated July 28, 2022Vaccine Strategies to Prevent Monkeypox -- Vaccine Information -- Planning Considerations for Health Departments and Providers -- Access to Vaccines -- Equity -- JYNNEOS Special Considerations -- ACAM2000 Special Considerations -- Reporting of Vaccine Adverse Events
Updated August 11, 2022Summary of ChangesOn 8/11/2022:\u2022 Added recommendations on how to monitor...
Table 6. Summary of Vaccination Administration Considerations for Specific Populations by Age and Me...
The Centers for Disease Control and Prevention (CDC) and state and local health departments continue...
What You Need to Know\u2022 Two vaccines licensed by the U.S. Food and Drug Administration (FDA) are...
Updated June 2, 2022When properly administered before an exposure, vaccines are effective at protect...
ACAM2000 is licensed by the U.S. Food and Drug Administration for immunization against smallpox dise...
Vaccination with JYNNEOS vaccine (Modified Vaccinia Ankara vaccine, Bavarian Nordic) to prevent monk...
Last Updated 09/27/22Note: The 2022 U.S. monkeypox outbreak is rapidly evolving. This document addre...
Updated May 5, 2023Mpox (formerly known as monkeypox) is caused by a virus that is related to the vi...
Updated August 31, 2022CDC recommends that vaccination with JYNNEOS can be considered for people det...
Smallpox/monkeypox vaccine (JYNNEOSTM) can help protect against smallpox, monkeypox, and other disea...
Updated September 15, 2022CDC is closely tracking cases of monkeypox recently detected in the United...
supersedes cdc:120269Updated August 22, 2022This document provides interim guidance for healthcare p...
Many individuals infected with monkeypox virus have a mild, self-limiting disease course in the abse...
Updated August 15, 2022Formerly called: Interim clinical considerations for use of JYNNEOS and ACAM2...
Updated August 11, 2022Summary of ChangesOn 8/11/2022:\u2022 Added recommendations on how to monitor...
Table 6. Summary of Vaccination Administration Considerations for Specific Populations by Age and Me...
The Centers for Disease Control and Prevention (CDC) and state and local health departments continue...
What You Need to Know\u2022 Two vaccines licensed by the U.S. Food and Drug Administration (FDA) are...
Updated June 2, 2022When properly administered before an exposure, vaccines are effective at protect...
ACAM2000 is licensed by the U.S. Food and Drug Administration for immunization against smallpox dise...
Vaccination with JYNNEOS vaccine (Modified Vaccinia Ankara vaccine, Bavarian Nordic) to prevent monk...
Last Updated 09/27/22Note: The 2022 U.S. monkeypox outbreak is rapidly evolving. This document addre...
Updated May 5, 2023Mpox (formerly known as monkeypox) is caused by a virus that is related to the vi...
Updated August 31, 2022CDC recommends that vaccination with JYNNEOS can be considered for people det...
Smallpox/monkeypox vaccine (JYNNEOSTM) can help protect against smallpox, monkeypox, and other disea...
Updated September 15, 2022CDC is closely tracking cases of monkeypox recently detected in the United...
supersedes cdc:120269Updated August 22, 2022This document provides interim guidance for healthcare p...
Many individuals infected with monkeypox virus have a mild, self-limiting disease course in the abse...
Updated August 15, 2022Formerly called: Interim clinical considerations for use of JYNNEOS and ACAM2...
Updated August 11, 2022Summary of ChangesOn 8/11/2022:\u2022 Added recommendations on how to monitor...
Table 6. Summary of Vaccination Administration Considerations for Specific Populations by Age and Me...
The Centers for Disease Control and Prevention (CDC) and state and local health departments continue...